Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer's disease
Authors:
- Alzheimer’s Disease Neuroimaging InitiativeAIAlzheimer’s Disease Neuroimaging Initiative
- Lan TanLTLan Tan
- Jin-Tai YuJYJin-Tai Yu
Open Access
- 21 July 2020
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 12 (14) , 14528-14541
Abstract
It was unclear whether sex hormone-binding globulin (SHBG) was a circulating biomarker of Alzheimer’s disease (AD). We tested the cross-sectional relationships between plasma SHBG and cerebrospinal fluid (CSF) AD biomarkers in 707 non-demented adults. Next, the influences of plasma SHBG on dynamic changes of CSF Aβ42, hippocampus volume, brain metabolism, and cognition were explored in 448 non-demented adults from the Alzheimer’s disease Neuroimaging Initiative (ADNI). Finally, the predictive and diagnostic values of plasma SHBG in AD were explored. A positive correlation was found between SHBG levels in plasma and CSF. Individuals with higher plasma SHBG levels had lower CSF Aβ42 (p < 0.005), after adjusting for age, gender, education, APOE4 allele, and cognitive scores. Though no significant difference of plasma SHBG was observed between mild AD dementia and healthy normal, plasma SHBG could contribute to accelerated rates of CSF Aβ42 decrease (p < 0.0005), decline in brain metabolism (p < 0.05), and hippocampus atrophy (p < 0.01), cognitive decline (p < 0.01), as well as higher risk of AD dementia (p < 0.05). These findings indicated plasma SHBG could be a prodromal biomarker to predict disease progression in AD.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Progesterone and neuroprotectionHormones and Behavior, 2013
- Sex hormone binding globulin and incident Alzheimer’s disease in elderly men and womenNeurobiology of Aging, 2010
- Alzheimer's Disease Neuroimaging Initiative (ADNI)Neurology, 2010
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- The Alzheimer's disease neuroimaging initiative (ADNI): MRI methodsJournal of Magnetic Resonance Imaging, 2008
- Hyporesponsiveness to Glucocorticoids in Mice Genetically Deficient for the Corticosteroid Binding GlobulinMolecular and Cellular Biology, 2006
- Changes in BMI modulate age-associated changes in sex hormone binding globulin and total testosterone, but not bioavailable testosterone in young adult men: the CARDIA Male Hormone StudyInternational Journal of Obesity, 2006
- Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing StudyClinical Endocrinology, 2006
- Elevated sex-hormone binding globulin in elderly women with Alzheimer’s diseaseNeurobiology of Aging, 2004
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984